Patents by Inventor Jianmei PANG

Jianmei PANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Double-stranded RNA molecule targeting CKIP-1 and use thereof
    Patent number: 11939578
    Abstract: The present invention relates to the field of biomedicine, particularly to double-stranded RNA molecules targeting CKIP-1 and uses thereof, particularly to use of the double-stranded RNA molecules for the treatment of inflammatory diseases such as arthritis, particularly rheumatoid arthritis.
    Type: Grant
    Filed: September 14, 2021
    Date of Patent: March 26, 2024
    Assignee: BEIJING TIDE PHARMACEUTICAL CO., LTD.
    Inventors: Yanping Zhao, Hongjun Wang, Yuanyuan Jiang, Weiting Zhong, Jianmei Pang, Gong Li, Xiang Li, Yixin He, Liying Zhou, Yanan Liu
  • SOLID FORM OF DIAMINOPYRIMIDINE COMPOUND OR HYDRATE THEREOF, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
    Publication number: 20220204475
    Abstract: The present invention relates to a solid form of 5-((2-ethynyl-5-isopropylpyridin-4-yl)oxy)pyrimidine-2,4-diamine or a hydrate thereof, a method for preparing the solid form, a pharmaceutical composition comprising the solid form, and a use of the solid form for the prevention or treatment of a disease modulated by P2X3 and/or P2X2/3 receptor antagonists.
    Type: Application
    Filed: April 29, 2020
    Publication date: June 30, 2022
    Inventors: CheungLing CHENG, Yanping ZHAO, Hongjun WANG, Zewang FENG, Huai HUANG, Kai LIU, Xuelian LIU, Jianmei PANG, Nana TIAN, Xichao CHEN, Shenzhen FU, Jie MENG, Liying ZHOU, Yanan LIU
  • SALT OF DIAMINOPYRIMIDINE COMPOUNDS, AND SOLID FORM THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF
    Publication number: 20220177447
    Abstract: The present invention relates to a salt of 5-((2-ethynyl-5-isopropylpyridin-4-yl)oxy)pyrimidine-2,4-diamine and a solid form thereof, a method for preparing the solid form and a pharmaceutical composition comprising the solid form, as well as a use of the solid form for preventing or treating diseases modulated by P2X3 and/or P2X2/3 receptor antagonists.
    Type: Application
    Filed: April 29, 2020
    Publication date: June 9, 2022
    Inventors: Yanping ZHAO, Hongjun WANG, Zewang FENG, Huai HUANG, Kai LIU, Xuelian Liu, Jianmei PANG, Nana TIAN, Xichao CHEN, Shenzhen FU, Jie MENG, Liying ZHOU, Yanan LIU
  • Double-stranded RNA Molecule Targeting CKIP-1 and Use Thereof
    Publication number: 20220064645
    Abstract: The present invention relates to the field of biomedicine, particularly to double-stranded RNA molecules targeting CKIP-1 and uses thereof, particularly to use of the double-stranded RNA molecules for the treatment of inflammatory diseases such as arthritis, particularly rheumatoid arthritis.
    Type: Application
    Filed: September 14, 2021
    Publication date: March 3, 2022
    Inventors: Yanping ZHAO, Hongjun WANG, Yuanyuan JIANG, Weiting ZHONG, Jianmei PANG, Gong LI, Xiang LI, Yixin HE, Liying ZHOU, Yanan LIU
  • RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF
    Publication number: 20220002266
    Abstract: A Rho-associated protein kinase (ROCK) inhibitor represented by formula (I), a pharmaceutical composition comprising same, and a use thereof for preventing or treating ROCK-mediated diseases.
    Type: Application
    Filed: November 8, 2019
    Publication date: January 6, 2022
    Inventors: Yanping ZHAO, Hongjun WANG, Gong LI, Yuanyuan JIANG, Xiang LI, Bin LIU, Kai LIU, Weiting ZHONG, Fajie LI, Jing ZHAO, Jianmei PANG, Liying ZHOU
  • Double-stranded RNA molecule targeting CKIP-1 and use thereof
    Patent number: 11155819
    Abstract: The present invention relates to the field of biomedicine, particularly to double-stranded RNA molecules targeting CKIP-1 and uses thereof, particularly to use of the double-stranded RNA molecules for the treatment of inflammatory diseases such as arthritis, particularly rheumatoid arthritis.
    Type: Grant
    Filed: September 7, 2018
    Date of Patent: October 26, 2021
    Assignee: BEIJING TIDE PHARMACEUTICAL CO., LTD.
    Inventors: Yanping Zhao, Hongjun Wang, Yuanyuan Jiang, Weiting Zhong, Jianmei Pang, Gong Li, Xiang Li, Yixin He, Liying Zhou, Yanan Liu
  • Double-stranded RNA Molecule Targeting CKIP-1 and Use Thereof
    Publication number: 20200231967
    Abstract: The present invention relates to the field of biomedicine, particularly to double-stranded RNA molecules targeting CKIP-1 and uses thereof, particularly to use of the double-stranded RNA molecules for the treatment of inflammatory diseases such as arthritis, particularly rheumatoid arthritis.
    Type: Application
    Filed: September 7, 2018
    Publication date: July 23, 2020
    Inventors: Yanping ZHAO, Hongjun WANG, Yuanyuan JIANG, Weiting ZHONG, Jianmei PANG, Gong LI, Xiang LI, Yixin HE, Liying ZHOU, Yanan LIU